<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30197027</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>10</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>10</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1769-6658</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>22</Volume>                    <Issue>6-7</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                    </PubDate>                </JournalIssue>                <Title>Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique</Title>                <ISOAbbreviation>Cancer Radiother</ISOAbbreviation>            </Journal>            <ArticleTitle>[Prevalence and expectations of &quot;alternative and complementary medicine&quot; use during radiotherapy in 2016: A prospective study].</ArticleTitle>            <Pagination>                <MedlinePgn>682-687</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S1278-3218(18)30265-8</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.canrad.2018.06.016</ELocationID>            <Abstract>                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Alternative and complementary medicine is defined as any substance or technique of non-allopathic medicine used to improve health and quality of life. The purpose of this prospective observational study was to evaluate the use of alternative and complementary medicine during radiotherapy.</AbstractText>                <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">A questionnaire was given the last week of treatment to all patients treated for breast cancer, prostate cancer or head and neck cancer in our centre in 2016.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">In 2016, 132 patients were included. Fifty-seven patients (43%) used alternative and complementary medicine during radiotherapy, more women (61%) than men (35%) (P=0.005). The use of alternative and complementary medicine varied according to locations: 44% of head and neck cancers, 57% of breast cancers and 24% of prostate cancers, but sex was the confounding factor. If alternative and complementary medicine was used before radiotherapy, 82% of patients used it during treatment, compared to 30% if they were naive (P&lt;10<sup>-7</sup>). Healing touch (68%), homeopathy (26%) and magnetisers (21%) were the most used alternative and complementary medicines. Sixty-one percent of patients used alternative and complementary medicine to reduce skin and mucosal side effects of treatments, 28% to improve well-being, and 9% to treat cancer. Seventy-two percent of all patients would advise their loved one to use an alternative and complementary medicine and 87% would like information about them in the hospital.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Alternative and complementary medicines are used more by women, and by patients who used them before radiotherapy. The desired effects are mainly to reduce the side effects of the treatments. More than 80% of patients, whether or not they use alternative and complementary medicine, demand medical information.</AbstractText>                <CopyrightInformation>Copyright © 2018. Published by Elsevier Masson SAS.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Dupin</LastName>                    <ForeName>C</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Service d'oncologie-radiothérapie, hôpital Haut-Lévêque, CHU de Bordeaux, avenue Magellan, 33600 Pessac, France. Electronic address: charles.dupin@chu-bordeaux.fr.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Arsène-Henry</LastName>                    <ForeName>A</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Service d'oncologie-radiothérapie, institut Curie, 26, rue d'Ulm, 75005 Paris, France. Electronic address: alexandre.aah@gmail.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Charleux</LastName>                    <ForeName>T</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Service d'oncologie-radiothérapie, hôpital Haut-Lévêque, CHU de Bordeaux, avenue Magellan, 33600 Pessac, France. Electronic address: thomas.charleux@chu-bordeaux.fr.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Haaser</LastName>                    <ForeName>T</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Service d'oncologie-radiothérapie, hôpital Haut-Lévêque, CHU de Bordeaux, avenue Magellan, 33600 Pessac, France. Electronic address: thibaud.haaser@chu-bordeaux.fr.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Trouette</LastName>                    <ForeName>R</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Service d'oncologie-radiothérapie, hôpital Haut-Lévêque, CHU de Bordeaux, avenue Magellan, 33600 Pessac, France. Electronic address: renaud.trouette@chu-bordeaux.fr.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Vendrely</LastName>                    <ForeName>V</ForeName>                    <Initials>V</Initials>                    <AffiliationInfo>                        <Affiliation>Service d'oncologie-radiothérapie, hôpital Haut-Lévêque, CHU de Bordeaux, avenue Magellan, 33600 Pessac, France. Electronic address: veronique.vendrely@chu-bordeaux.fr.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>fre</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <VernacularTitle>Prévalence et attentes de l’utilisation des « médecines alternatives et complémentaires » pendant la radiothérapie en 2016 : étude prospective.</VernacularTitle>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>06</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>France</Country>            <MedlineTA>Cancer Radiother</MedlineTA>            <NlmUniqueID>9711272</NlmUniqueID>            <ISSNLinking>1278-3218</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000529" MajorTopicYN="N">Complementary Therapies</DescriptorName>                <QualifierName UI="Q000656" MajorTopicYN="Y">utilization</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D010039" MajorTopicYN="N">Otorhinolaryngologic Neoplasms</DescriptorName>                <QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011471" MajorTopicYN="N">Prostatic Neoplasms</DescriptorName>                <QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Alternative and complementary medicine</Keyword>            <Keyword MajorTopicYN="N">Epidemiology</Keyword>            <Keyword MajorTopicYN="N">Homeopathy</Keyword>            <Keyword MajorTopicYN="N">Homéopathie</Keyword>            <Keyword MajorTopicYN="N">Médecines alternatives et complémentaires</Keyword>            <Keyword MajorTopicYN="N">Soins de support</Keyword>            <Keyword MajorTopicYN="N">Supportive care</Keyword>            <Keyword MajorTopicYN="N">Épidémiologie</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>06</Month>                <Day>14</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>06</Month>                <Day>28</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>11</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>12</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>11</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30197027</ArticleId>            <ArticleId IdType="pii">S1278-3218(18)30265-8</ArticleId>            <ArticleId IdType="doi">10.1016/j.canrad.2018.06.016</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>